ALK	Anaplastic lymphoma kinase
EML4	Echinoderm microtubule-associated protein-like 4
NSCLC	Non-small-cell lung cancer
EGFR	Epidermal growth factor receptor
TKIs	Tyrosine kinase inhibitors
ICI	Immune checkpoint inhibitor
ABCP	Atezorizumab + bevacizumab + carboplatin + paclitaxel
PFS	Progression-free survival
OS	Overall survival
HR	Hazard ratio
CI	Confidence interval
PD-L1	Programmed death-ligand 1
KRAS	v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog
HER2	Human epidermal growth factor receptor type 2
BRAF	B-Raf proto-oncogene, serine/threonine kinase
ORR	Objective response rate
TIL	Tumor-infiltrating lymphocytes
CRP	C-reactive protein
LDH	Lactate dehydrogenase
NLR	Neutrophil-to-lymphocyte ratio
PCR	Reverse transcriptase
IHC	Immunohistochemistry
FISH	Fluorescence in situ hybridization